CLOV vs INM · rev $1.37B vs rev $4.9M
Clover Health Investments Corp (CLOV) versus InMed Pharmaceuticals Inc (INM) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
InMed Pharmaceuticals Inc (INM) is a drug manufacturers - specialty & generic company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported INM revenue for 2025-06-30 was $4.9M. Net income was -$8.2M. Revenue was up 7.5% from 2024-06-30 to 2025-06-30. INM currently screens at market cap $5.2M.
CLOV currently screens at market cap $1.55B. INM currently screens at market cap $5.2M.
Not investment advice. Open the CLOV and INM stock pages for the full models.
Not investment advice.